Portland, OR, Nov. 15, 2022 (GLOBE NEWSWIRE) -- A new business intelligence report released by Allied Market Research, the global Joint Pain Injections Market size garnered $6.3 billion in 2021, and is estimated to generate $13.2 billion by 2031, manifesting a CAGR of 7.7% from 2022 to 2031. The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers a valuable guidance to leading players, investors, shareholders, and startups in devising strategies for the sustainable growth and gaining competitive edge in the market.
Download Free Sample Report: https://www.alliedmarketresearch.com/request-sample/31909
Report coverage & details:
| Report Coverage | Details |
| Forecast Period | 2022–2031 |
| Market Size in 2021 | $6.3 billion |
| Market Size in 2031 | $13.2 billion |
| CAGR | 7.7% |
| No. of Pages in Report | 310 |
| Segments covered | Injection Type, Joint Type, Distribution Channel, and Region. |
| Drivers | Rise in elderly population |
| High prevalence of the obese population | |
| Rise in prevalence of osteoarthritis and rheumatoid arthritis | |
| Increase in need for affordable treatments for different kinds of arthritis | |
| Surge in demand for joint pain injections due to rise in prevalence of accidental injuries that leads to joint pain | |
| Opportunities | Research and development activities to invent more efficient treatment options which includes the single injection therapy, platelet-rich plasma, prolotherapy, autologous conditioned serum and plasma matrix therapy |
| Restraints | Expensive treatment |
Covid-19 Scenario:
- The outbreak of the COVID-19 pandemic had a negative impact on the growth of the global joint pain injections market, as it registered decline in sales of the joint pain injections.
- Many key market players registered the decrease in their revenues from the joint pain injection segments, which was mainly due to decline in the patient visit to the hospitals, reallocation of the healthcare resources, and effect on the supply chain around the globe.
- However, with ease in restrictions, the demand for joint pain injections is likely to increase in the post-pandemic.
The research provides detailed segmentation of the global joint pain injections market based on Type, Joint Injection Type, Distribution Channel, and region. The report discusses segments and their sub-segments in detail with the help of tables and figures. Market players and investors can strategize according to the highest revenue-generating and fastest-growing segments mentioned in the report.
Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/31909
Based on injection type, the interleukin inhibitors segment held the highest share in 2031, accounting for more than half of the global joint pain injections market. However, the hyaluronic acid injections segment is expected to register the highest CAGR of 14.7% from 2022 to 2031.
Based on joint type, the Knee and Ankle segment accounted for the highest share in 2021, contributing to nearly two-fifths of the global joint pain injections market, and is expected to maintain its lead in terms of revenue during the forecast period. However, the hip joint segment is expected to manifest the highest CAGR of 8.8% from 2022 to 2031.
Based on distribution channel, the drug stores and retail pharmacies segment accounted for the highest share in 2021, holding more than half of the global joint pain injections market, and is expected to continue its leadership status during the forecast period. However, the online providers segment is estimated to grow at the highest CAGR of 10.3% during the forecast period.
Based on region, North America held the largest share in 2021, contributing to more than two-fifths of the global joint pain injections market share, and is projected to maintain its dominant share in terms of revenue in 2031. In addition, the Asia-Pacific region is expected to manifest the fastest CAGR of 9.5% during the forecast period. The research also analyzes regions including Europe and LAMEA.
Leading market players of the global joint pain injections market analyzed in the research include Abbvie Inc, Anika Therapeutics, Bioventus, Eli Lilly and Company, Ferring Pharmaceuticals Inc., PACIRA BIOSCIENCES (Flexion Therapeutics, Inc.), Pfizer Inc., Sanofi S.A., Teva Pharmaceuticals, Zimmer Biomet.
The report provides a detailed analysis of these key players of the global joint pain injections market. These players have adopted different strategies such as new product launches, collaborations, expansion, joint ventures, agreements, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
Trending Reports in Healthcare Industry (Book Now with 10% Discount):
Scaffold Technology Market by Product Type (Natural Scaffold, Sythetic Scaffold), by Type (Macro-Porous Scaffolds, Micro-Porous Scaffolds, Nano-Porous Scaffolds, Solid Scaffolds), by Application (Cancer cell research, Stem cell research, Drug discovery, Regenerative medicine), by End User (Biotechnology & pharmaceutical companies, Contract Research laboratories, Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2021-2031
U.S. Home Medical Equipment Market by Functionality (Therapeutic Equipment, Patient Monitoring Equipment, and Mobility Assist & Patient Support Equipment) and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Retailers): Opportunity Analysis and Industry Forecast, 2020-2030
Companion Animal Diagnostics Market By Technology (Clinical Biochemistry, Immunodiagnostics, Molecular Diagnostics, Hematology, Urinalysis, Others), By Application (Clinical Pathology, Bacteriology, Virology, Parasitology, Other Applications), By Animal Type (Dogs, Cats, Others), By End User (Diagnostic Labs, Veterinary Hospitals and Clinics, Point-Of-Care and In-House Testing, Research Institutes and Universities): Global Opportunity Analysis and Industry Forecast, 2021-2031
Healthcare Gamification Market By Game Type (Exercise Games, Serious Games, Casual Games), By Application (Education, Therapeutics, Prevention), By End User (Enterprise Based, Consumer Based): Global Opportunity Analysis and Industry Forecast, 2021-2031
Fertility Test Market by Product (Ovulation Prediction Kits, Fertility Monitors, and Male Fertility Testing Products), Mode of Purchase (OTC-based and Prescription-based), Application (Female Fertility Testing and Male Fertility Testing), and End User (Home Care Settings and Hospitals/Fertility Clinics): Global Opportunity Analysis and Industry Forecast, 2021-2030
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
